CareLit · DOI-Nachweis · Senologie - Zeitschrift für Mammadiagnostik und -therapie
Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial
DOI 10.1055/s-0033-1347542
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Banys, E Solomayer, G Gebauer, W Janni, H Lueck, S Becker, J Huober, B Krämer, B Wackwitz, P Hirnle, D Wallwiener, T Fehm
ZeitschriftSenologie - Zeitschrift für Mammadiagnostik und -therapie
Ausgabe06/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: The presence of disseminated tumor cells (DTC) in bone marrow (BM) of breast cancer patients is associated with reduced clinical outcome. Bisphosphonate treatment was shown to eradicate DTC. This controlled study aimed to investigate the influence of zoledronic acid (ZOL) on DTC and survival of breast cancer patients. Methods: Patients with primary breast cancer and DTC-positive bone marrow were random…
Zitieren
Zitierempfehlung
M Banys, E Solomayer, G Gebauer, W Janni, H Lueck, S Becker, J Huober, B Krämer, B Wackwitz, P Hirnle, D Wallwiener, T Fehm (2013) Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial. Senologie - Zeitschrift für Mammadiagnostik und -therapie (06). https://doi.org/10.1055/s-0033-1347542
Mit CareLit weiterarbeiten